STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. MDCX
  4. [ARS] Medicus Pharma Ltd. SEC Filing

[ARS] Medicus Pharma Ltd. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Medicus Pharma Ltd.

ARS Filing - Medicus Pharma Ltd.

This filing is available as a PDF document.

Filing Type: ARS

Company: Medicus Pharma Ltd. (MDCX)

Acceptance Date: 2025-06-30T17:01:04.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock MDCX logo
Medicus Pharma Ltd

NASDAQ:MDCX

MDCX Rankings

#5445 Ranked by Market Cap
N/A Ranked by Dividends

MDCX Latest News

Oct 29, 2025
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome
Oct 22, 2025
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Oct 14, 2025
The Vanderbilt Report: Medicus Pharma Ltd Built Three Separate Billion-Dollar Bets
Oct 13, 2025
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
Oct 7, 2025
Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE

MDCX Latest SEC Filings

Oct 17, 2025
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)
Oct 17, 2025
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)
Oct 17, 2025
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)
Oct 17, 2025
[8-K] Medicus Pharma Ltd. Reports Material Event
Sep 29, 2025
[S-1] Medicus Pharma Ltd. Files IPO Registration Statement

MDCX Stock Data

50.21M
13.17M
35.91%
14.9%
1.87%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
Canada
W. CONSHOHOCKEN